Author's response: Critical need for robust surveillance in response to DENV-2 and SARS-CoV-2 cross-reactivity

Euro Surveill. 2024 May;29(19):2400270. doi: 10.2807/1560-7917.ES.2024.29.19.2400270.

Authors

Raphaëlle Klitting^{1

2}, Xavier de Lamballerie^{1

2}; all co-authors of the original article³

Affiliations

¹ National Reference Center for Arboviruses, Inserm-IRBA, Marseille, France.
² Unité des Virus Émergents (UVE: Aix-Marseille Univ, Università di Corsica, IRD 190, Inserm 1207, IRBA), Marseille, France.
³ https://www.eurosurveillance.org/content/10.2807/1560-7917.ES.2024.29.13.2400123.

PMID: 38726695
PMCID: PMC11083976
DOI: 10.2807/1560-7917.ES.2024.29.19.2400270

No abstract available

Keywords: dengue fever; pathogenesis; surveillance.

Publication types

Letter

MeSH terms

Antibodies, Viral / blood
COVID-19* / epidemiology
Cross Reactions*
Dengue Virus* / isolation & purification
Dengue* / diagnosis
Dengue* / epidemiology
Humans
Population Surveillance
SARS-CoV-2*

Substances

Antibodies, Viral